Plasma levels of C-reactive protein: a cardiovascular risk factor indicator in overweight and obese Sudanese adults

Sahar Siddig Gamil, Khalid Hussein Bakheit, Mohammad Eltaher Adam

Abstract


Background: C-reactive protein (CRP) is a member of the class of acute-phase reactants, as its levels rise
dramatically during inflammatory processes occurring in the body. This increment is due to a rise in the
plasma concentration of IL-6, which is produced predominantly by macrophages as well as adipocytes. This
study aims to test whether overweight and obesity are associated with low-grade systemic inflammation as
measured by serum C-reactive protein (CRP) level.
Methods: The study involved 20-60 years old Sudanese. Body weight and height were measured
using standardized procedures. Blood samples were drawn in plain containers; Serum specimens for the
measurement of CRP were analyzed using a high-sensitivity CPR test.
Results: The sample of the present study has included 41 males and 20 females with an age range between
18 and 52 years, the sample was divided into 3 groups according to their body mass index into 21 normal
weight (BMI=22.17±1.45 ), 20 overweight ( BMI= 27.68± 1.15 ) and 20 obese (BMI= 34.15± 3.54 ). The
normal weight group had the lowest levels of C-reactive protein (2.15 ±2.52 mg/l) and obese the highest
(3.95± 2.78 mg/l). Plasma levels of C-reactive protein showed a positive and significant correlation with
body mass index (p< 0.05).
Conclusion: This study has shown that, in Sudanese adults, a positive and significant relationship was
observed between levels of CRP and measures of obesity (BMI). In addition, a relation was found between
obesity and risk of developing cardiovascular diseases, these findings suggest a state of low-grade systemic
inflammation in overweight and obese persons. This result study extends recent observations made by
other investigators.

Keywords


Plasma; levels of ;C-reactive ;protein; a cardiovascular ;risk; factor; indicator in ;overweight and obese; Sudanese ;adults

Full Text:

PDF

References


Bourne LT, Lambert EV, Steyn K. Where does

the black population of South Africa stand on

the nutrition transition? Public Health Nutr

; 5:157-162.

A.O. Musaiger. Overweight and obesity in the

Eastern Mediterranean Region: can we control

it? Eastern Mediterranean Health Journal

;10:789-93.

Sundquist K, Malmstrom M, Johansson SE:

Neighbourhood deprivation and incidence of

coronary heart disease: a multilevel study of 2.6

million women and men in Sweden. J Epidemiol

Community Health 2004, 58:71-77.

Kuga S, Njelekela M, Noguchi T, et al.

Prevalence of overweight and hypertension in

Tanzania: special emphasis on resting energy

expenditure and leptin. Clin Exp Pharmacol

Physiol Suppl 2002, 29: 23-26.

Department of Health. South Africa

Demographic and Health Survey 1998. Full

report.

Pepys, MB; Hirschfield, GM.C-reactive protein:

a critical update.J Clin Invest 2003; 111:1805–

Lau DC, Dhillon B, Yan H et al.Adipokines:

molecular links between obesity and

Sahar Siddig Gamil, Khalid Hussein Bakheit, Mohammad Eltaher Adam

atheroslcerosis. Am J Physiol Heart Circ

Physiol 2004; 288: 2031–41.

Alexander J. Szalai. The biological functions

of C-reactive protein. Vascular Pharmacology

; 39:105-107

Mohamed-Ali V, Goodrick S, Rawesh A,

et al. Subcutaneous adipose tissue releases

interleukin-6, but not tumor necrosis factor-α, in

vivo. J Clin Endocrinol Metab. 1997;82:4196-

Caro JF1, Sinha MK, Kolaczynski JW, Zhang

PL, Considine RV. Leptin: the tale of an obesity

gene.Diabetes1996; 45:1455–1462.

P. Calabro,, D.W. Chang,, J.T. Willerson, and

E. T.H. Yeh,. Release of C-Reactive Protein

in Response to Inflammatory Cytokines

by Human Adipocytes: Linking Obesity to

Vascular Inflammation,J Am Coll Cardiol

; 46:1112-1113,

Ridker PM, Cushman M, Stampfer MJ, Tracy

RP, Hennekens CH. Inflammation, aspirin, and

the risk of cardiovascular disease in apparently

healthy men. N Engl J Med 1997; 336: 973–

Ridker PM, Hennekens CH, Buring JE, Rifai

N. C-reactive protein and other markers of

inflammation in the prediction of cardiovascular

disease in women. N Engl J Med 2000; 342:

–843.

Ridker PM, Cushman M, Stampfer MJ, Tracy

RP, Hennekens CH. Plasma concentration

of C-reactive protein and risk of developing

peripheral vascular disease. Circulation 1998;

: 425–428.

Koenig W, Sund M, Frohlich M, et al.

C-reactive protein, a sensitive marker of

inflammation, predicts future risk of coronary

heart disease in initially healthy middle-aged

men: results from the MONICA (Monitoring

Trends and Determinants in Cardiovascular

Disease) Augsburg Cohort Study, 1984–1992.

Circulation 1999; 99:237–242.

Danesh J, Collins R, Appleby P, Peto R.

Association of fibrinogen, C-reactive protein,

albumin, or leukocyte count with coronary

heart disease: meta-analyses of prospective

studies. JAMA 1998; 279: 1477–1482.

Griselli M, Herbert J, Hutchinson WL, et

al. C-reactive protein and complement are

important mediators of tissue damage in acute

myocardial infarction. J Exp Med 1999; 190:

–1740.

WHO. Obesity: preventing and managing

the global epidemic. Report of a WHO

Consultation. WHO Technical Report Series

Geneva: World Health Organization, 2000.

Visser M, Bouter LM, McQuillan GM, Wener

MH, Harris TB. Elevated C-Reactive Protein

Levels in Overweight and Obese Adults. JAMA.

;282:2131-2135.

Elisabeth Hak, Coen D. A. Stehouwer,

Michiel L. Bots, Kees H. Polderman, Casper

G. Schalkwijk, Iris C. D. Westendorp, Albert

Hofman, and Jacqueline C. M. Witteman.

Associations of C-Reactive Protein With

Measures of Obesity, Insulin Resistance, and

Subclinical Atherosclerosis in Healthy, Middle-

Aged Women.Arterioscler Thromb Vasc Biol.

;19:1986-1991

Forouhi NG, Sattar N, McKeigue PM. Relation

of C-reactive protein to body fat distribution

and features of the metabolic syndrome in

Europeans and South Asians. Int J Obes Relat

Metab Disord. 2001;25: 1327-1331.

Hotamisligil GS, Shargill NS, Spiegelman BM.

Adipose expression of tumor necrosis factor-α:

direct role in obesity-linked insulin resistance.

Science 1993; 259:87–91.

Khera A, McGuire DK, Murphy SA, et al. Race

and Gender Differences in C-Reactive Protein

Levels. J Am Coll Cardio 2005 ;46:464-469


Refbacks

  • There are currently no refbacks.


ISSN: 1858-5345